These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds. Noell CW; Cheng CC J Med Chem; 1968 Jan; 11(1):63-6. PubMed ID: 4966062 [No Abstract] [Full Text] [Related]
5. SYNTHESIS OF POTENTIAL DUAL ANTAGONISTS IV. EFFECT OF RING SUBSTITUENTS ON THE ALKYLATING AND HYDROLYTIC PROPERTIES OF BIS-(1-AZIRIDINYL)PHOSPHINYL CARBAMATES. BARDOS TJ; CHMIELEWICZ ZF; NAVADA CK J Pharm Sci; 1965 Mar; 54():399-403. PubMed ID: 14302149 [No Abstract] [Full Text] [Related]
6. Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes. van der Huizen AA; Wilting T; van de Grampel JC; Lelieveld P; van der Meer-Kalverkamp A; Lamberts HB; Mulder NH J Med Chem; 1986 Aug; 29(8):1341-5. PubMed ID: 3735303 [TBL] [Abstract][Full Text] [Related]
7. Potential anticancer agents. V. New aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid. Cambanis A; Dobre V; Niculescu-Duvăz I J Med Chem; 1969 Jan; 12(1):161-4. PubMed ID: 5763014 [No Abstract] [Full Text] [Related]
8. Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains. Hsiao YY; Bardos TJ J Med Chem; 1973 Apr; 16(4):391-4. PubMed ID: 4716182 [No Abstract] [Full Text] [Related]
9. [Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt]. de Leval J; Petit R; Bouffioux C Acta Urol Belg; 1974 Jul; 42(3):326-35. PubMed ID: 4440596 [No Abstract] [Full Text] [Related]
10. [Chemotherapy of malignant tumors. 44]. Seidenglanz G Pharm Prax; 1970; 6():122-38. PubMed ID: 4917035 [No Abstract] [Full Text] [Related]
11. SYNTHESIS OF POTENTIAL "DUAL ANTAGONISTS." I. SOME BIS(1-AZIRIDINYL)PHOSPHINYL CARBAMATES AND THEIR STRUCTURAL ANALOGS. PAPANASTASSIOU ZB; BARDOS TJ J Med Pharm Chem; 1962 Sep; 5():1000-7. PubMed ID: 14056423 [No Abstract] [Full Text] [Related]
12. [Results of the clinical study of a preparation of diiodobenzotef in malignant tumors]. Karev NI; Garin AM; Blokhina NG; Pershin MP; Trapeznikova MF Klin Med (Mosk); 1975 May; 52(5):50-3. PubMed ID: 1133992 [No Abstract] [Full Text] [Related]
13. Estrogen-linked cytotoxic agents of potential value for the treatment of breast cancer. Leclercq G; Devleeschouwer N; Legros N; Heuson JC Eur J Cancer (1965); 1980; Suppl 1():287-93. PubMed ID: 7318866 [No Abstract] [Full Text] [Related]
14. [Structure-activity relationship in Mannich bases with and without nitrogen mustard groups and in various reduction products derived from beta-aminoketones as evidenced with the aid of a cancerostatic 3-step test using transplantation tumors]. Werner W; Jungstand W; Gutsche W; Wohlrabe K Pharmazie; 1977 Jun; 32(6):341-7. PubMed ID: 896938 [No Abstract] [Full Text] [Related]
15. Potential anticancer agents. II. Urethan-type nitrogen mustards of some natural sex hormones. Niculescu-Duvăz I; Cambanis A; Tărnăuceanu E J Med Chem; 1967 Mar; 10(2):172-4. PubMed ID: 6034059 [No Abstract] [Full Text] [Related]
16. Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850). Pütter J; Maral R; Bierling R; Steinhoff D Farmaco Sci; 1971 Sep; 26(9):784-804. PubMed ID: 5157546 [No Abstract] [Full Text] [Related]
17. Potential anticancer agents. VII. Relationship between basicity of precursor unsubstituted amines and hydrolysis rate of corresponding aromatic nitrogen mustards. Niculescu-Duvaz I; Botez G; Serban A Neoplasma; 1970; 17(2):143-54. PubMed ID: 5425392 [No Abstract] [Full Text] [Related]
18. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate. Müntzing J; Shukla SK; Chu TM; Mittelman A; Murphy GP Invest Urol; 1974 Jul; 12(1):65-8. PubMed ID: 4835492 [No Abstract] [Full Text] [Related]
19. Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines. Palmer BD; Wilson WR; Pullen SM; Denny WA J Med Chem; 1990 Jan; 33(1):112-21. PubMed ID: 2296009 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, antineoplastic activity, and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethyl)imidazole. Anderson WK; Bhattacharjee D; Houston DM J Med Chem; 1989 Jan; 32(1):119-27. PubMed ID: 2909723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]